Stock Analysis on Net
Stock Analysis on Net

Abbott Laboratories (NYSE:ABT) 

Analysis of Inventory

Microsoft Excel

Inventory Disclosure

Abbott Laboratories, balance sheet: inventory

US$ in millions

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Finished products 3,700 3,946 3,805 3,081 3,030
Work in process 840 807 680 694 712
Materials 1,654 1,817 1,688 1,382 1,270
Inventories 6,194 6,570 6,173 5,157 5,012

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

Item Description The company
Inventories Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. Abbott Laboratories inventories increased from 2022 to 2023 but then slightly decreased from 2023 to 2024 not reaching 2022 level.